The Chinese pharmaceutical market has found stability with a focus on medical devices and innovative drugs, leading to optimism among investors.

Chinese battery material companies encounter hurdles in their quest for global market dominance, while Japanese counterparts struggle to catch up.

The Chinese tech giant’s January-March revenue misses analyst bets with a 2% growth.

Security concerns and lack of market access drives crackdowns around the world.

This leadership change comes as Chinese e-retailer’s Q1 results beat expectations.

LinkedIn’s InCareer app in China is set to be shut down as the Microsoft-owned platform faces fierce competition and slower revenue growth.

This latest moves aims to capture market share from rivals like Meituan and Douyin.

Li Auto aims to transform its business with new organizational changes introduced by CEO Li Xiang, with full results expected no earlier than 2025.